EGFR and non-small cell lung carcinoma: The aim of this literature overview is to analyze the role of the combination of metastasis directed therapy, focusing on RT, in combination with TKIs in patients with EGFR mutated oligometastatic and/or oligoprogressive advanced NSCLC.